UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Reinsurance Group of America
RGA
$16.7B
| $53.9M | 0.01% |
253,530
-275
| -0.1% | -$57.4K |
2013 Q2
52 quarters
|
|
627
American Healthcare REIT
AHR
$11.1B
| $53.7M | 0.01% |
1,030,254
+1,028,580
| +61,444% | +$50.5M |
2024 Q2
8 quarters
|
|
628
Lantheus
LNTH
$6.54B
| $53.6M | 0.01% |
482,743
-3,755
| -0.8% | -$350K |
2018 Q1
33 quarters
|
|
629
Beam Therapeutics
BEAM
$2.65B
| $53.3M | 0.01% |
1,551,781
-101,933
| -6% | -$3.08M |
2020 Q4
22 quarters
|
|
|
WCC
630
WESCO International
WCC
$17.8B
| $53.1M | 0.01% |
153,650
-2,800
| -2% | -$950K |
2013 Q2
52 quarters
|
|
|
GOOGM
631
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
| $52.9M | 0.01% |
+1,040,000
| New | +$52.2M |
2026 Q2
0 quarters
|
|
632
Shift4
FOUR
$3.16B
| $52.7M | 0.01% |
1,082,866
-50,447
| -4% | -$2.18M |
2020 Q2
24 quarters
|
|
633
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.01B
| $52.5M | 0.01% |
2,232,045
-1,892,583
| -46% | -$44.1M |
2025 Q4
2 quarters
|
|
634
Nextpower Inc. Common Stock
NXT
$13.1B
| $52.4M | 0.01% |
439,844
+154,365
| +54% | +$19M |
2023 Q3
11 quarters
|
|
635
Match Group
MTCH
$9.43B
| $52.2M | 0.01% |
1,372,344
+203,959
| +17% | +$7.23M |
2017 Q1
37 quarters
|
|
636
Cirrus Logic
CRUS
$5.36B
| $52.2M | 0.01% |
351,409
-63,272
| -15% | -$10.4M |
2013 Q2
52 quarters
|
|
637
ITT
ITT
$18B
| $52.2M | 0.01% |
263,749
+6,333
| +2% | +$1.28M |
2013 Q2
52 quarters
|
|
638
Armstrong World Industries
AWI
$6.84B
| $51.7M | 0.01% |
322,458
-1,185
| -0.4% | -$194K |
2013 Q2
52 quarters
|
|
639
Vanguard Dividend Appreciation ETF
VIG
$111B
| $51.7M | 0.01% |
218,582
-8,985
| -4% | -$2.06M |
2025 Q3
3 quarters
|
|
640
Modine Manufacturing
MOD
$9.64B
| $51.7M | 0.01% |
193,619
+72,253
| +60% | +$19M |
2021 Q2
20 quarters
|
|
641
Charles River Laboratories
CRL
$14.4B
| $51.1M | 0.01% |
225,314
+6,401
| +3% | +$1.14M |
2013 Q2
52 quarters
|
|
642
Huazhu Hotels Group
HTHT
$13.9B
| $50.8M | 0.01% |
1,216,507
+1,214,004
| +48,502% | +$57.9M |
2017 Q4
34 quarters
|
|
643
RBC Bearings
RBC
$15.9B
| $50.5M | 0.01% |
78,430
+22,721
| +41% | +$13.5M |
2013 Q2
52 quarters
|
|
644
Albemarle
ALB
$12B
| $50.5M | 0.01% |
373,918
+75,934
| +25% | +$13.4M |
2013 Q2
52 quarters
|
|
645
Privia Health
PRVA
$2.66B
| $50.1M | 0.01% |
1,948,021
-103,638
| -5% | -$2.4M |
2022 Q1
17 quarters
|
|
646
Ryman Hospitality Properties
RHP
$8.3B
| $49.9M | 0.01% |
387,804
+385,625
| +17,697% | +$42.8M |
2025 Q4
2 quarters
|
|
|
TEM
647
Tempus AI
TEM
$12.9B
| $49.7M | 0.01% |
858,529
+96,428
| +13% | +$4.83M |
2025 Q1
5 quarters
|
|
648
Royal Gold
RGLD
$20B
| $49.7M | 0.01% |
248,893
-2,259
| -0.9% | -$525K |
2013 Q2
52 quarters
|
|
649
Aramark
ARMK
$14.5B
| $49.5M | 0.01% |
870,271
-4,153
| -0.5% | -$205K |
2015 Q1
45 quarters
|
|
650
iShares MSCI Taiwan ETF
EWT
$12.5B
| $49.2M | 0.01% |
453,195
+389,833
| +615% | +$36.5M |
2025 Q1
5 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.